查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1917889

安寧療護市場—2026-2031年預測

Palliative Care Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2025 年，安寧療護市場規模將達到 154.56 億美元，到 2031 年將達到 235.81 億美元，複合年成長率為 7.29%。

安寧療護市場是更廣泛的醫療保健系統中一個重要且不斷成長的組成部分，其重點在於改善面臨嚴重、複雜且往往危及生命的疾病的患者的生活品質。與安寧療護不同，安寧療護適用於嚴重的任何階段，並且可以與治癒性治療同時進行。其核心使命是透過對疼痛、呼吸困難和噁心等生理症狀進行專業管理來減輕患者的痛苦，同時為患者及其家屬提供心理社會和精神支持。推動市場成長的因素包括人口趨勢、醫療保健服務模式轉移，以及安寧療護原則日益融入標準醫療實踐。

關鍵成長要素包括全球嚴重慢性疾病盛行率的上升和社會老化。隨著人口壽命的延長，諸如晚期癌症、心臟衰竭、慢性阻塞性肺病和神經退化性疾病等複雜進行性性疾病的負擔顯著增加。這些疾病通常伴隨嚴重的症狀負擔和功能衰退，因此迫切需要安寧療護提供的專業且全面的支持。這種人口和流行病學現實造就了龐大且不斷成長的安寧療護受益患者群體，從而確保了對安寧療護服務的持續需求。

同時，病人、家屬和醫護人員對安寧療護的認知和接受度不斷提高，也是推動安寧療護發展的重要因素。倡導團體、專業協會和醫療機構的教育努力逐漸轉變了人們的觀念，使安寧療護不再僅僅被視為臨終關懷，而是成為高品質、全面性嚴重疾病治療的重要組成部分。人們越來越認知到，早期引入安寧療護可以改善患者預後，提高患者滿意度，在某些情況下甚至可以延長存活期。這種文化轉變正在消除以往對安寧療護的偏見，鼓勵更早轉診，並就治療目標展開更公開的討論。

塑造市場格局的關鍵趨勢之一是將安寧療護積極融入主流醫療保健系統和政策。這不再局限於獨立的安寧療護項目，而是將安寧療護理念和專業團隊融入腫瘤科、心臟科和神經科等醫療專科。醫療機構正在發展住院會診服務、專科門診，並在責任醫療組織（ACO）內建立嵌入式安寧療護模式。推動這一整合的依據是，有證據表明安寧療護有助於降低醫院再入院率，減少臨終階段不必要的過度治療，並使醫療服務與病人的價值觀相契合——這些都是基於價值的醫療報銷模式的關鍵指標。

為滿足病患意願和提高醫療效率，居家安寧療護服務的需求顯著成長。大多數患者都希望盡可能長時間地留在自己家中。居家模式直接為患者提供多學科護理，包括護理、醫生監督、社工服務和心理治療，在舒適宜人的環境中管理複雜的症狀並提供支持。此模式已展現出顯著減少急診就診和住院次數的潛力，在尊重患者自主權的同時，也為支付方提供了一種經濟高效的選擇。居家醫療基礎設施的擴展和遠端醫療能力的提升，正進一步推動這項轉變。

從地理上看，歐洲通常被認為是安寧療護發展和整合領域的領導者，這得益於其健全的政策框架、政府主導的舉措以及較高的公眾意識。許多歐洲國家製定了國家安寧療護發展策略，並推動將其納入全民健康覆蓋（UHC）。這項既定基礎造就了比其他許多地區更成熟的市場和更廣泛的服務覆蓋率。

此服務模式具有跨學科性質，需要醫生、高級執業醫師、護士、社工、牧師和治療師之間的協作。服務在多種場所提供：住院會診團隊、專門的住院病房、門診診所、家庭護理項目以及長期護理機構。多樣化的服務場所確保了護理的連續性，並能夠適應不斷變化的患者需求和病情嚴重程度。

競爭格局呈現出多元化的服務提供者組成，包括專業的安寧療護機構、已拓展至安寧療護領域的大型居家醫療和臨終關懷機構、醫院和醫療系統旗下的項目，以及非營利組織。成功的關鍵在於：透過改善患者報告的療效和降低醫療資源利用率來展現明確的臨床價值；透過與支付方和醫療系統簽訂合約來獲得永續的報酬；以及在競爭激烈的領域中吸引和留住專業的臨床人才。

總之，安寧療護市場正從一項輔助服務發展成為現代醫療保健中應對嚴重疾病的重要組成部分。其成長得益於結構性因素：人口趨勢和慢性病管理日益複雜化。未來，持續向基於價值的支付模式轉型、居家服務的成功推廣、在非腫瘤診斷領域的進一步滲透，以及透過培訓和教育不斷提升臨床能力，都將推動安寧療護市場的發展。這一市場軌跡反映了醫療服務理念的根本性轉變，即優先考慮患者的生活品質、目標以及在整個嚴重病程中提供全面的支持。

本報告的主要優勢：

  • 深入分析：提供對主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
  • 競爭格局：了解全球主要參與者的策略舉措，並了解透過正確的策略進入市場的機會。
  • 市場促進因素與未來趨勢：探討影響市場的動態因素和關鍵趨勢及其對未來市場發展的影響。
  • 可操作的建議：利用這些見解，在動態環境中做出策略決策，並開拓新的商機和收入來源。
  • 受眾廣泛：適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業，且經濟實惠。

您打算如何使用這份報告？

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

  • 2021年至2025年的歷史數據和2026年至2031年的預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區（包括國家）分類的收入和預測評估
  • 公司概況（策略、產品、財務資訊、關鍵發展等）

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

第5章 按類型分類的安寧療護市場

  • 介紹
  • 居家臨終關懷
  • 護理中心的安寧療護
  • 醫院的安寧療護
  • 住院安寧療護

第6章 按應用領域分類的安寧療護市場

  • 介紹
  • 癌症
  • 心血管疾病
  • 神經系統疾病
  • 慢性腎臟病
  • 呼吸系統疾病
  • 其他

第7章 按年齡層別分類的安寧療護市場

  • 介紹
  • 孩子們
  • 成人
  • 老年人

第8章 各地區的安寧療護市場

  • 介紹
  • 北美洲
    • 按類型
    • 透過使用
    • 按年齡層
    • 按國家/地區
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按類型
    • 透過使用
    • 按年齡層
    • 按國家/地區
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 按類型
    • 透過使用
    • 按年齡層
    • 按國家/地區
      • 德國
      • 法國
      • 英國
      • 西班牙
      • 義大利
      • 其他
  • 中東和非洲
    • 按類型
    • 透過使用
    • 按年齡層
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 按類型
    • 透過使用
    • 按年齡層
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 印尼
      • 泰國
      • 台灣
      • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第10章：公司簡介

  • Chemed Corporation
  • Humana Inc.
  • Gentiva
  • Amedisys, Inc.
  • AccentCare Inc.
  • Crossroads Hospice & Palliative Care
  • Caris Healthcare, LP
  • Compassus
  • Sunrise Senior Living（Revera）
  • Home Instead, Inc.（Honor Technology, Inc）

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061615954

Palliative Care Market is expected to grow at a 7.29% CAGR, increasing to USD 23.581 billion in 2031 from USD 15.456 billion in 2025.

The palliative care market is a critical and expanding segment within the broader healthcare continuum, focused on improving the quality of life for patients facing serious, complex, and often life-limiting illnesses. Distinct from hospice care, palliative medicine is appropriate at any stage of a serious illness and can be provided alongside curative treatment. Its core mission is the relief of suffering through expert management of physical symptoms-such as pain, dyspnea, and nausea-coupled with the provision of psychosocial and spiritual support for both patients and their families. The market's growth is driven by the convergence of demographic trends, a shifting paradigm in healthcare delivery towards value and patient-centeredness, and increasing integration of palliative principles into standard medical practice.

A primary growth catalyst is the rising global prevalence of serious chronic illnesses and an aging population. As populations live longer, the burden of complex, progressive conditions like advanced cancer, heart failure, chronic obstructive pulmonary disease, and neurodegenerative diseases increases substantially. These conditions often involve significant symptom burdens and functional decline, creating a profound need for the specialized, holistic support that palliative care provides. This demographic and epidemiological reality establishes a large and growing patient population that benefits from palliative intervention, ensuring sustained demand for services.

Concurrently, the increasing awareness and acceptance of palliative care among patients, families, and healthcare professionals is a significant driver. Educational initiatives by advocacy organizations, professional societies, and healthcare institutions have progressively shifted perceptions, moving palliative care from a modality associated solely with the end of life to a recognized component of high-quality, comprehensive care for serious illness. There is greater understanding that early integration of palliative care can improve patient outcomes, enhance satisfaction, and in some cases, even extend survival. This cultural shift is reducing historical stigma and is encouraging earlier referrals and more open discussions about goals of care.

A major trend shaping the market is the active integration of palliative care into mainstream healthcare systems and policies. This is moving beyond standalone programs toward embedding palliative care principles and specialist teams within oncology, cardiology, neurology, and other specialty departments. Healthcare institutions are establishing inpatient consultation services, dedicated outpatient clinics, and embedded models within accountable care organizations. This integration is driven by evidence demonstrating that palliative care can reduce hospital readmissions, decrease unnecessary and aggressive care at the end of life, and improve care alignment with patient values-key metrics in value-based reimbursement models.

Aligned with patient preference and healthcare efficiency, there is a pronounced increase in demand for home-based palliative care services. Most patients express a desire to remain at home for as long as possible. Home-based models deliver interdisciplinary care-including nursing, physician oversight, social work, and therapy-directly to the patient, managing complex symptoms and providing support in a preferred, comfortable setting. This model has demonstrated significant potential to reduce emergency department visits and hospitalizations, making it economically favorable for payers while honoring patient autonomy. The growth of home health infrastructure and telehealth capabilities is further enabling this shift.

Geographically, Europe is often regarded as a leader in the development and integration of palliative care, supported by strong policy frameworks, government-led initiatives, and a high level of public awareness. Many European countries have national strategies for palliative care development and have worked to ensure its inclusion in universal health coverage. This established foundation fosters a more mature market with broader access compared to many other regions.

The service delivery model is inherently interdisciplinary, requiring collaboration between physicians, advanced practice providers, nurses, social workers, chaplains, and therapists. Services are delivered across multiple settings: inpatient hospital consultation teams, dedicated inpatient units, outpatient clinics, home-based programs, and within long-term care facilities. The variety of settings allows for a continuum of care that can adapt to changing patient needs and acuity levels.

The competitive landscape includes a diverse mix of providers: specialized palliative care organizations, large home health and hospice agencies that have expanded into palliative care, hospital and health system-based programs, and nonprofit entities. Success depends on the ability to demonstrate clear clinical value through improved patient-reported outcomes and reduced healthcare utilization, secure sustainable reimbursement through contracts with payers and health systems, and recruit and retain specialized clinical talent in a competitive field.

In conclusion, the palliative care market is evolving from a complementary service into an essential component of modern healthcare for serious illness. Its growth is structurally supported by demographic trends and the increasing complexity of chronic disease management. Future expansion will be shaped by the continued movement towards payment models that reward its value, successful scaling of home-based delivery, further penetration into non-cancer diagnoses, and ongoing efforts to build clinical capacity through training and education. The market's trajectory reflects a fundamental reorientation towards care that prioritizes quality of life, patient goals, and holistic support throughout the course of a serious illness.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Palliative Care Market Segmentation

  • By Type
  • Palliative Care At Homes
  • Palliative Care in Care Center
  • Palliative Care in Hospitals
  • Inpatient Palliative Care
  • By Application
  • Cancer
  • Cardiovascular Disease
  • Neurological Disorder
  • Chronic Kidney Disease
  • Respiratory Disease
  • Others
  • By Age-Group
  • Pediatric
  • Adult
  • Elderly
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PALLIATIVE CARE MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Palliative Care At Homes
  • 5.3. Palliative Care in Care Center
  • 5.4. Palliative Care in Hospitals
  • 5.5. Inpatient Palliative Care

6. PALLIATIVE CARE MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Cancer
  • 6.3. Cardiovascular Disease
  • 6.4. Neurological Disorder
  • 6.5. Chronic Kidney Disease
  • 6.6. Respiratory Disease
  • 6.7. Others

7. PALLIATIVE CARE MARKET BY AGE-GROUP

  • 7.1. Introduction
  • 7.2. Pediatric
  • 7.3. Adult
  • 7.4. Elderly

8. PALLIATIVE CARE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Age-Group
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Application
    • 8.3.3. By Age-Group
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Application
    • 8.4.3. By Age-Group
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Spain
      • 8.4.4.5. Italy
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Application
    • 8.5.3. By Age-Group
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Application
    • 8.6.3. By Age-Group
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. India
      • 8.6.4.3. Japan
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Taiwan
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Chemed Corporation
  • 10.2. Humana Inc.
  • 10.3. Gentiva
  • 10.4. Amedisys, Inc.
  • 10.5. AccentCare Inc.
  • 10.6. Crossroads Hospice & Palliative Care
  • 10.7. Caris Healthcare, L.P.
  • 10.8. Compassus
  • 10.9. Sunrise Senior Living (Revera)
  • 10.10. Home Instead, Inc. (Honor Technology, Inc)

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations